Stay updated on Lanabecestat in Early Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.

Latest updates to the Lanabecestat in Early Alzheimer's Disease Clinical Trial page
- Check3 days agoChange DetectedThe study page now displays a 403 Forbidden error, preventing access to the study record and related content.SummaryDifference18%

- Check10 days agoChange DetectedThe page shows a new revision label: Revision: v3.7.0, replacing Revision: v3.6.6, indicating an updated version of the page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, signaling a minor patch or build update. No user-facing content or functionality appears to be altered.SummaryDifference0.0%

- Check31 days agoChange DetectedA new NIH grant/contract identifier (2014) was added to the study's Other Study ID Numbers, expanding the funding references associated with the trial. This update links the AMARANTH study to an additional NIH funding record.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page’s revision tag was updated to v3.6.5, indicating a small build-level update to the page.SummaryDifference0.0%

- Check66 days agoChange DetectedA new revision version has been released: v3.6.4 replaces the prior v3.6.3. This indicates a minor patch or update to the underlying system or documentation powering the page.SummaryDifference0.0%

Stay in the know with updates to Lanabecestat in Early Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.